Heyman Richard A.

EDGAR CIK 0001584759

Enliven Therapeutics, Inc. - ELVN

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
4
($413,379)
-16,380 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/17/2026
10b5-1
02/19/2026
Sell
-1,230 @ $26.18
 ($32,196) 22,647 (-5.15%) Indirect - See footnote
01/20/2026
10b5-1
01/22/2026
Sell
-1,230 @ $26.75
 ($32,902) 23,877 (-4.90%) Indirect - See footnote
01/09/2026
10b5-1
01/12/2026
Sell
-4,285 @ $25.00
 ($107,125) 25,107 (-14.58%) Indirect - See footnote
01/08/2026
10b5-1
01/12/2026
Sell
-9,635 @ $25.03
 ($241,156) 29,392 (-24.69%) Indirect - See footnote

Oric Pharmaceuticals, Inc. - ORIC

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
1
($42,016)
-3,500 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($38,415)
-3,200 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/16/2026
10b5-1
01/20/2026
Sell
-3,500 @ $12.00
 ($42,016) 41,800 (-7.73%) Direct
01/16/2026
10b5-1
01/20/2026
Sell
-3,200 @ $12.00
 ($38,415) 213,072 (-1.48%) Indirect - See footnote